Developing treatments for rhodopsin-related dominant retinitis pigmentosa by Orlans, H

Data for "Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa" by Orlans, H

In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review by Orlans, H, Hornby, S, Bowler, I

Secretory cells of the supraoptic nucleus have central as well as neurohypophysial projections by Inyushkin, A, Orlans, H, Dyball, R

Osmotic modulation of stimulus-evoked responses in the rat supraoptic nucleus by Bhumbra, G, Orlans, H, Dyball, R

Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK by Gupta, A, Orlans, H, Hornby, S, Bowler, I

Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina by Patrício, M, Barnard, A, Orlans, H, McClements, M, MacLaren, R

Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis by Salvetti, A, Patrício, M, Barnard, A, Orlans, H, Hickey, D, MacLaren, R

A novel achromatopsia mouse model resulting from a naturally occurring missense change in Cngb3 by Hassall, M, Barnard, A, Orlans, H, McClements, M, Charbel Issa, P, Aslam, S, Maclaren, R

Anti-VEGF therapy and the retina: an update by Tah, V, Orlans, H, Hyer, J, Casswell, E, Din, N, Sri Shanmuganathan, V, Ramskold, L, Pasu, S

Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia by Xue, K, Jolly, J, Barnard, A, Rudenko, A, Salvetti, A, Patrício, M, Edwards, T, Groppe, M, Orlans, H, Tolmachova, T, Black, G, Webster, A, Lotery, A, Holder, G, Downes, S, Seabra, M, MacLaren, R